Coexistent Choriocarcinoma and Malignant Mixed Mesodermal Tumor of the Uterus

By Nguyen C.P.   Levi A.W.   Montz F.J.   Bristow R.E.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 499-503

Elsevier

Access to resources Recommend Favorite

Malignant Mixed Mesodermal Ovarian Tumor Treatment and Prognosis: A 20-Year Experience

By Le T.   Krepart G.V.   Lotocki R.J.   Heywood M.S.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 237-240

Elsevier

Access to resources Recommend Favorite

Parity as an Independent Prognostic Factor in Malignant Mixed Mesodermal Tumors of the Endometrium

By Marth C.   Windbichler G.   Petru E.   Dirschlmayer W.   Obermair A.   Czerwenka K.   Muller-Holzner E.   Dapunt O.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 121-125

Elsevier

Access to resources Recommend Favorite

The Expression of Epidermal Growth Factor Receptor, HER-2/ Neu, p53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma

By Swisher E.M.   Gown A.M.   Skelly M.   Ek M.   Tamimi H.K.   Cain J.M.   Greer B.E.   Muntz H.G.   Goff B.A.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 81-88

Academic Press

Access to resources Recommend Favorite

Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals

By Vaccher E.   Spina M.   Tirelli U.  

European Journal of Cancer, Vol. 37, Iss. 10, 2001-07 ,pp. : 1306-1315

Elsevier

Access to resources Recommend Favorite